Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 15, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012970.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized protein LOC393502 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein zgc:66455 isoform X2
uncharacterized protein LOC393502 homolog, transcript variant X1
uncharacterized protein zgc:66455 isoform X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2a, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2a, transcript variant X2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2a, transcript variant X1
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2a
copper metabolism (Murr1) domain containing 1, transcript variant X1
copper metabolism (Murr1) domain containing 1, transcript variant X3
copper metabolism (Murr1) domain containing 1, transcript variant X2
COMM domain-containing protein 1 isoform X2
COMM domain-containing protein 1 isoform X1
COMM domain-containing protein 1 isoform X3
chaperonin containing TCP1, subunit 4 (delta)
ATP-binding cassette, sub-family B (MDR/TAP), member 10
ATP-binding cassette sub-family B member 10, mitochondrial
nuclear pore complex protein Nup133 isoform X1
nuclear pore complex protein Nup133 isoform X3
nuclear pore complex protein Nup133 isoform X2
programmed cell death 2, transcript variant X2
programmed cell death 2, transcript variant X1
programmed cell death protein 2 isoform X2
programmed cell death protein 2 isoform X1
centriole, cilia and spindle-associated protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nitric oxide synthase, brain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nitric oxide synthase, brain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nitric oxide synthase, brain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nitric oxide synthase, brain-like isoform X3
nitric oxide synthase, brain-like isoform X2
nitric oxide synthase, brain-like isoform X1
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 25 member 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 25 member 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
solute carrier family 25 member 14, transcript variant X1
brain mitochondrial carrier protein 1 isoform X2
brain mitochondrial carrier protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclic nucleotide-gated olfactory channel-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal assembly factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dynein axonemal assembly factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nucleoporin 62 like, transcript variant X2
nucleoporin 62 like, transcript variant X1
nucleoporin 62 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-4-like isoform X1
gamma-aminobutyric acid receptor subunit beta-4-like isoform X2
gamma-aminobutyric acid receptor subunit alpha-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-3-like, transcript variant X1
gamma-aminobutyric acid receptor subunit alpha-3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-3-like, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-3-like isoform X1
gamma-aminobutyric acid receptor subunit alpha-3-like isoform X3
gamma-aminobutyric acid receptor subunit alpha-3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-3-like isoform X2
gamma-aminobutyric acid receptor subunit gamma-4-like, transcript variant X1
gamma-aminobutyric acid receptor subunit gamma-4-like, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-4-like isoform X1
gamma-aminobutyric acid receptor subunit gamma-4-like isoform X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor
transcription initiation factor TFIID subunit 7
uncharacterized protein LOC494104 homolog, transcript variant X1
uncharacterized protein LOC494104 homolog, transcript variant X2
uncharacterized protein LOC494104 homolog, transcript variant X3
translocase of inner mitochondrial membrane 8 homolog A (yeast)
mitochondrial import inner membrane translocase subunit Tim8 A
Bruton agammaglobulinemia tyrosine kinase, transcript variant X2
Bruton agammaglobulinemia tyrosine kinase, transcript variant X3
Bruton agammaglobulinemia tyrosine kinase, transcript variant X1
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
glycine receptor, alpha 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glycine receptor, alpha 4a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glycine receptor, alpha 4a, transcript variant X1
glycine receptor, alpha 4a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glycine receptor, alpha 4a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X1
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X3
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X4
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X2
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X1
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X3
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X4
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X6
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X5
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X6
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X7
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X5
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X7
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
interferon-inducible GTPase 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
interferon-inducible GTPase 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
interferon-inducible GTPase 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
interferon-inducible GTPase 5-like isoform X2
interferon-inducible GTPase 5-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tRNA (uracil(54)-C(5))-methyltransferase homolog-B
muscleblind-like protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X7
muscleblind-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
muscleblind-like protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transfer RNA serine (anticodon ACU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
FERM domain-containing protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FERM domain-containing protein 7-like, transcript variant X1
FERM domain-containing protein 7-like isoform X1
FERM domain-containing protein 7-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
interleukin-13 receptor subunit alpha-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
dedicator of cytokinesis 11, transcript variant X1
dedicator of cytokinesis protein 11 isoform X1
dedicator of cytokinesis 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dedicator of cytokinesis 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dedicator of cytokinesis protein 11 isoform X3
dedicator of cytokinesis protein 11 isoform X2
dedicator of cytokinesis 11, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dedicator of cytokinesis protein 11 isoform X4
dedicator of cytokinesis 11, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dedicator of cytokinesis protein 11 isoform X5
dedicator of cytokinesis 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dedicator of cytokinesis protein 11 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
T-cell-specific guanine nucleotide triphosphate-binding protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: T-cell-specific guanine nucleotide triphosphate-binding protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
diacylglycerol kinase eta, transcript variant X3
diacylglycerol kinase eta, transcript variant X1
diacylglycerol kinase eta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
kelch-like protein 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
kelch-like protein 13, transcript variant X2
kelch-like protein 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kelch-like protein 13, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kelch-like protein 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat domain 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
WD repeat domain 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
WD repeat-containing protein 44 isoform X1
WD repeat-containing protein 44 isoform X2
WD repeat domain 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
WD repeat domain 44, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
WD repeat-containing protein 44 isoform X3
WD repeat-containing protein 44 isoform X4
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like, transcript variant X1
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like, transcript variant X2
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like isoform X2
tRNA (uracil(54)-C(5))-methyltransferase homolog-B-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122557095, transcript variant X1
uncharacterized LOC122557095, transcript variant X2
sodium-dependent serotonin transporter-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
U2 snRNP-associated SURP motif-containing protein-like, transcript variant X2
U2 snRNP-associated SURP motif-containing protein-like, transcript variant X1
U2 snRNP-associated SURP motif-containing protein-like, transcript variant X3
U2 snRNP-associated SURP motif-containing protein-like isoform X2
U2 snRNP-associated SURP motif-containing protein-like isoform X1
U2 snRNP-associated SURP motif-containing protein-like isoform X3
MICOS complex subunit MIC27-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
MICOS complex subunit MIC27-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
MICOS complex subunit MIC27-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
MICOS complex subunit MIC27-like isoform X3
MICOS complex subunit MIC27-like isoform X1
MICOS complex subunit MIC27-like isoform X2
connector enhancer of kinase suppressor of ras 2, transcript variant X1
connector enhancer of kinase suppressor of ras 2 isoform X1
connector enhancer of kinase suppressor of ras 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
connector enhancer of kinase suppressor of ras 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
highly divergent homeobox, transcript variant X8
highly divergent homeobox, transcript variant X6
highly divergent homeobox, transcript variant X5
highly divergent homeobox, transcript variant X11
highly divergent homeobox, transcript variant X10
highly divergent homeobox, transcript variant X3
highly divergent homeobox, transcript variant X7
highly divergent homeobox, transcript variant X9
highly divergent homeobox, transcript variant X1
highly divergent homeobox, transcript variant X2
highly divergent homeobox, transcript variant X4
ribosomal protein S6 kinase a, like, transcript variant X1
ribosomal protein S6 kinase alpha-6 isoform X1
ribosomal protein S6 kinase a, like, transcript variant X2
ribosomal protein S6 kinase alpha-6 isoform X2
ribosomal protein S6 kinase a, like, transcript variant X3
ribosomal protein S6 kinase alpha-6 isoform X3
ribosomal protein S6 kinase a, like, transcript variant X4
ribosomal protein S6 kinase alpha-6 isoform X4
POU domain, class 3, transcription factor 4-B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor subfamily 0 group B member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
TLR adapter interacting with SLC15A4 on the lysosome-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
SH3 domain binding glutamate-rich protein like, transcript variant X1
SH3 domain binding glutamate-rich protein like, transcript variant X2
SH3 domain-binding glutamic acid-rich-like protein isoform X1
SH3 domain-binding glutamic acid-rich-like protein isoform X2
high mobility group nucleosomal binding domain 7, transcript variant X2
high mobility group nucleosomal binding domain 7 isoform X2
high mobility group nucleosomal binding domain 7, transcript variant X1
high mobility group nucleosomal binding domain 7 isoform X1
bromodomain and WD repeat domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
bromodomain and WD repeat domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
bromodomain and WD repeat domain containing 3, transcript variant X1
bromodomain and WD repeat-containing protein 3 isoform X1
bromodomain and WD repeat-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
terminal nucleotidyltransferase 5C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
terminal nucleotidyltransferase 5C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromatin modifying protein 1B, transcript variant X2
chromatin modifying protein 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
hydroxyacid oxidase 2-like, transcript variant X2
hydroxyacid oxidase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hydroxyacid oxidase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hydroxyacid oxidase 2-like, transcript variant X1
G protein-coupled receptor 174, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein-coupled receptor 174, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
G protein-coupled receptor 174, transcript variant X1
probable G-protein coupled receptor 174, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable G-protein coupled receptor 174, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable G-protein coupled receptor 174, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable G-protein coupled receptor 174, transcript variant X5
probable G-protein coupled receptor 174, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable G-protein coupled receptor 174, transcript variant X3
probable G-protein coupled receptor 174, transcript variant X7
probable G-protein coupled receptor 174 isoform X1
probable G-protein coupled receptor 174 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
type-1 angiotensin II receptor-like, transcript variant X2
type-1 angiotensin II receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cysteinyl leukotriene receptor 1-like, transcript variant X1
cysteinyl leukotriene receptor 1-like, transcript variant X2
fibronectin type-III domain-containing protein 3A-like, transcript variant X3
fibronectin type-III domain-containing protein 3A-like, transcript variant X1
fibronectin type-III domain-containing protein 3A-like, transcript variant X4
fibronectin type-III domain-containing protein 3A-like, transcript variant X5
fibronectin type-III domain-containing protein 3A-like isoform X2
fibronectin type-III domain-containing protein 3A-like, transcript variant X2
fibronectin type-III domain-containing protein 3A-like isoform X1
fibronectin type-III domain-containing protein 3A-like isoform X3
fibronectin type-III domain-containing protein 3A-like isoform X4
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor
transcription initiation factor TFIID subunit 9
succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial-like
5-hydroxytryptamine receptor 2A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
5-hydroxytryptamine receptor 2A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 2A-like isoform X2
5-hydroxytryptamine receptor 2A-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
interleukin-13 receptor subunit alpha-2-like
leucine-rich repeats and calponin homology (CH) domain containing 2, transcript variant X1
leucine-rich repeats and calponin homology (CH) domain containing 2, transcript variant X2
leucine-rich repeats and calponin homology (CH) domain containing 2, transcript variant X3
leucine-rich repeat and calponin homology domain-containing protein 2 isoform X2
leucine-rich repeat and calponin homology domain-containing protein 2 isoform X3
leucine-rich repeat and calponin homology domain-containing protein 2 isoform X1
leucine-rich repeats and calponin homology (CH) domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat and calponin homology domain-containing protein 2 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
UAP56-interacting factor-like, transcript variant X1
UAP56-interacting factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
UAP56-interacting factor-like isoform X1
UAP56-interacting factor-like isoform X2
chloride intracellular channel protein 2-like, transcript variant X2
chloride intracellular channel protein 2-like, transcript variant X1
chloride intracellular channel protein 2-like isoform X1
chloride intracellular channel protein 4-like isoform X2
urotensin-related peptide 1, transcript variant X1
urotensin-related peptide 1, transcript variant X3
urotensin-related peptide 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
urotensin-related peptide 1, transcript variant X4
interferon alpha/beta receptor 1-like, transcript variant X4
interferon alpha/beta receptor 1-like, transcript variant X1
interferon alpha/beta receptor 1-like, transcript variant X5
interferon alpha/beta receptor 1-like, transcript variant X2
interferon alpha/beta receptor 1-like, transcript variant X3
interferon alpha/beta receptor 1-like isoform X3
interferon alpha/beta receptor 1-like isoform X2
interferon alpha/beta receptor 1-like isoform X1
apoptosis inducing factor mitochondrion associated 1
apoptosis-inducing factor 1, mitochondrial
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
E74-like ETS transcription factor 1, transcript variant X2
E74-like ETS transcription factor 1, transcript variant X5
E74-like ETS transcription factor 1, transcript variant X1
E74-like ETS transcription factor 1, transcript variant X3
E74-like ETS transcription factor 1, transcript variant X4
ETS-related transcription factor Elf-1 isoform X1
ETS-related transcription factor Elf-1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
diaphanous-related formin 2, transcript variant X3
diaphanous-related formin 2, transcript variant X2
diaphanous-related formin 2, transcript variant X4
diaphanous-related formin 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
kelch-like protein 4, transcript variant X1
kelch-like protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 33-like, transcript variant X3
transmembrane protein 33-like, transcript variant X1
transmembrane protein 33-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 33-like isoform X2
transmembrane protein 33-like isoform X1
transmembrane protein 33-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CHM Rab escort protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
rab proteins geranylgeranyltransferase component A 1 isoform X1
CHM Rab escort protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
rab proteins geranylgeranyltransferase component A 1 isoform X2
zinc finger protein 711, transcript variant X1
zinc finger protein 711, transcript variant X2
uncharacterized protein LOC555281 homolog
ADP-ribosylation factor-like protein 13B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dystrophin related protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dystrophin related protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dystrophin related protein 2, transcript variant X1
dystrophin related protein 2, transcript variant X6
dystrophin related protein 2, transcript variant X3
dystrophin related protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1, transcript variant X2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1, transcript variant X5
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1, transcript variant X3
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
histone deacetylase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
histone deacetylase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
histone deacetylase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
phosphorylase kinase, alpha 1a (muscle), transcript variant X2
phosphorylase kinase, alpha 1a (muscle), transcript variant X8
phosphorylase kinase, alpha 1a (muscle), transcript variant X9
phosphorylase kinase, alpha 1a (muscle), transcript variant X7
phosphorylase kinase, alpha 1a (muscle), transcript variant X6
phosphorylase kinase, alpha 1a (muscle), transcript variant X5
phosphorylase kinase, alpha 1a (muscle), transcript variant X4
phosphorylase kinase, alpha 1a (muscle), transcript variant X3
phosphorylase kinase, alpha 1a (muscle), transcript variant X1
phosphorylase kinase, alpha 1a (muscle), transcript variant X10
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X7
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X8
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X6
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X5
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X4
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X3
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X2
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X1
phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform isoform X9
protein (peptidylprolyl cis/trans isomerase) NIMA-interacting, 4 (parvulin)
peptidyl-prolyl cis-trans isomerase NIMA-interacting 4
transmembrane gamma-carboxyglutamic acid protein 3, transcript variant X1
transmembrane gamma-carboxyglutamic acid protein 3, transcript variant X3
transmembrane gamma-carboxyglutamic acid protein 3, transcript variant X2
transmembrane gamma-carboxyglutamic acid protein 3 isoform X1
transmembrane gamma-carboxyglutamic acid protein 3 isoform X2
transmembrane gamma-carboxyglutamic acid protein 3, transcript variant X4
transmembrane gamma-carboxyglutamic acid protein 3 isoform X3
transmembrane gamma-carboxyglutamic acid protein 3, transcript variant X6
transmembrane gamma-carboxyglutamic acid protein 3, transcript variant X5
transmembrane gamma-carboxyglutamic acid protein 3 isoform X4
transmembrane gamma-carboxyglutamic acid protein 3 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
synaptotagmin-like 4, transcript variant X2
synaptotagmin-like 4, transcript variant X1
synaptotagmin-like 4, transcript variant X3
tRNA wybutosine-synthesizing protein 2 homolog
cleavage stimulation factor, 3' pre-RNA, subunit 2, transcript variant X1
cleavage stimulation factor, 3' pre-RNA, subunit 2, transcript variant X4
cleavage stimulation factor, 3' pre-RNA, subunit 2, transcript variant X3
cleavage stimulation factor, 3' pre-RNA, subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cleavage stimulation factor subunit 2 isoform X1
cleavage stimulation factor subunit 2 isoform X3
cleavage stimulation factor subunit 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
coagulation factor VIII, procoagulant component
C-x(9)-C motif containing 4 homolog (S. cerevisiae), transcript variant X3
C-x(9)-C motif containing 4 homolog (S. cerevisiae), transcript variant X2
C-x(9)-C motif containing 4 homolog (S. cerevisiae), transcript variant X1
BRCA1/BRCA2-containing complex, subunit 3
G protein-coupled receptor 34 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein-coupled receptor 34 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
membrane palmitoylated protein 1, transcript variant X1
membrane palmitoylated protein 1, transcript variant X2
55 kDa erythrocyte membrane protein isoform X1
55 kDa erythrocyte membrane protein isoform X2
dyskeratosis congenita 1, dyskerin, transcript variant X3
dyskeratosis congenita 1, dyskerin, transcript variant X2
dyskeratosis congenita 1, dyskerin, transcript variant X1
H/ACA ribonucleoprotein complex subunit DKC1 isoform X3
H/ACA ribonucleoprotein complex subunit DKC1 isoform X2
H/ACA ribonucleoprotein complex subunit DKC1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00340
COORDINATES: nucleotide motif:Rfam:12.0:RF00137
COORDINATES: nucleotide motif:Rfam:12.0:RF00567
trimethyllysine dioxygenase, mitochondrial
Ras-related GTP binding A, transcript variant X2
Ras-related GTP binding A, transcript variant X1
ras-related GTP-binding protein A isoform X1
ras-related GTP-binding protein A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
short coiled-coil protein B, transcript variant X1
short coiled-coil protein B, transcript variant X4
short coiled-coil protein B, transcript variant X3
short coiled-coil protein B, transcript variant X2
protein sprouty homolog 2, transcript variant X7
protein sprouty homolog 2, transcript variant X3
protein sprouty homolog 2, transcript variant X2
protein sprouty homolog 2, transcript variant X4
protein sprouty homolog 2, transcript variant X6
protein sprouty homolog 2, transcript variant X1
protein sprouty homolog 2, transcript variant X5
brain-specific homeobox/POU domain protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA-directed RNA polymerases I and III subunit RPAC2
synaptobrevin-like 1, transcript variant X3
synaptobrevin-like 1, transcript variant X2
synaptobrevin-like 1, transcript variant X4
synaptobrevin-like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
synaptobrevin-like 1, transcript variant X1
vesicle-associated membrane protein 7 isoform X3
vesicle-associated membrane protein 7 isoform X1
vesicle-associated membrane protein 7 isoform X2
SLAIN motif-containing protein-like, transcript variant X3
SLAIN motif-containing protein-like, transcript variant X2
SLAIN motif-containing protein-like, transcript variant X1
SLAIN motif-containing protein-like isoform X2
SLAIN motif-containing protein-like isoform X1
NAD(P) dependent steroid dehydrogenase-like, transcript variant X2
NAD(P) dependent steroid dehydrogenase-like, transcript variant X1
sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating isoform X2
sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ecto-NOX disulfide-thiol exchanger 2, transcript variant X2
ecto-NOX disulfide-thiol exchanger 2, transcript variant X4
ecto-NOX disulfide-thiol exchanger 2, transcript variant X1
ecto-NOX disulfide-thiol exchanger 2, transcript variant X3
ecto-NOX disulfide-thiol exchanger 2, transcript variant X5
ecto-NOX disulfide-thiol exchanger 2 isoform X2
ecto-NOX disulfide-thiol exchanger 2 isoform X1
ecto-NOX disulfide-thiol exchanger 2 isoform X3
ecto-NOX disulfide-thiol exchanger 2 isoform X4
multidrug resistance-associated protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multidrug resistance-associated protein 5-like, transcript variant X3
multidrug resistance-associated protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multidrug resistance-associated protein 5-like isoform X1
multidrug resistance-associated protein 5-like isoform X3
multidrug resistance-associated protein 5-like isoform X2
multidrug resistance-associated protein 5-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
multidrug resistance-associated protein 5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multidrug resistance-associated protein 5-like isoform X5
multidrug resistance-associated protein 5-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multidrug resistance-associated protein 5-like, transcript variant X4
multidrug resistance-associated protein 5-like isoform X4
multidrug resistance-associated protein 5-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
multidrug resistance-associated protein 5-like isoform X6
tumor necrosis factor ligand superfamily member 10-like
fibrous sheath-interacting protein 2-like
seven in absentia homolog 2 (Drosophila)-like
RNA-binding motif protein, X-linked 2-like
glucose-dependent insulinotropic receptor, transcript variant X2
glucose-dependent insulinotropic receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glucose-dependent insulinotropic receptor
Kruppel-like factor 8, transcript variant X1
Kruppel-like factor 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
potassium channel tetramerisation domain containing 12b, transcript variant X1
potassium channel tetramerisation domain containing 12b, transcript variant X2
BTB/POZ domain-containing protein KCTD12b isoform X2
BTB/POZ domain-containing protein KCTD12b isoform X1
potassium channel tetramerisation domain containing 12b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BTB/POZ domain-containing protein KCTD12b isoform X4
potassium channel tetramerisation domain containing 12b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD12b isoform X3
exocyst complex component 1-like, transcript variant X5
exocyst complex component 1-like, transcript variant X2
exocyst complex component 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
exocyst complex component 1-like, transcript variant X3
exocyst complex component 1-like isoform X1
exocyst complex component 1-like isoform X2
exocyst complex component 1-like isoform X3
exocyst complex component 1-like isoform X5
exocyst complex component 1-like, transcript variant X4
exocyst complex component 1-like isoform X4
exocyst complex component 1-like, transcript variant X6
exocyst complex component 1-like isoform X6
uncharacterized si:ch211-153b23.3, transcript variant X2
uncharacterized si:ch211-153b23.3, transcript variant X1
uncharacterized protein si:ch211-153b23.3 isoform X1
uncharacterized protein si:ch211-153b23.3 isoform X2
uncharacterized protein LOC565650 homolog
probable alpha-ketoglutarate-dependent hypophosphite dioxygenase
uncharacterized protein LOC321177 homolog
glutamine amidotransferase-like class 1 domain-containing protein 3A, mitochondrial
uncharacterized protein LOC335392 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC335392 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC335392 homolog, transcript variant X3
uncharacterized protein LOC335392 homolog, transcript variant X1
uncharacterized protein si:ch211-153b23.4
sushi-repeat containing protein X-linked 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sushi-repeat containing protein X-linked 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sushi-repeat containing protein X-linked 2, transcript variant X2
BCL-6 corepressor-like protein 1, transcript variant X1
BCL-6 corepressor-like protein 1, transcript variant X2
BCL-6 corepressor-like protein 1, transcript variant X3
BCL-6 corepressor-like protein 1 isoform X1
BCL-6 corepressor-like protein 1 isoform X2
uncharacterized LOC122557218, transcript variant X2
uncharacterized LOC122557218, transcript variant X1
uncharacterized protein LOC553498 homolog
U3 small nucleolar RNA-associated protein 14 homolog A
zinc finger DHHC-type palmitoyltransferase 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
OCRL inositol polyphosphate-5-phosphatase, transcript variant X1
OCRL inositol polyphosphate-5-phosphatase, transcript variant X2
inositol polyphosphate 5-phosphatase OCRL isoform X1
inositol polyphosphate 5-phosphatase OCRL isoform X2
OCRL inositol polyphosphate-5-phosphatase, transcript variant X5
OCRL inositol polyphosphate-5-phosphatase, transcript variant X3
inositol polyphosphate 5-phosphatase OCRL isoform X3
inositol polyphosphate 5-phosphatase OCRL isoform X5
OCRL inositol polyphosphate-5-phosphatase, transcript variant X4
inositol polyphosphate 5-phosphatase OCRL isoform X4
protein eva-1 homolog C, transcript variant X1
protein eva-1 homolog C, transcript variant X2
RAB33A, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RAB33A, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
methionyl-tRNA synthetase 2, mitochondrial
G2/mitotic-specific cyclin-B3 isoform X3
G2/mitotic-specific cyclin-B3 isoform X1
G2/mitotic-specific cyclin-B3 isoform X2
uncharacterized si:dkey-171c9.3, transcript variant X1
uncharacterized protein si:dkey-171c9.3 isoform X1
uncharacterized si:dkey-171c9.3, transcript variant X2
uncharacterized protein si:dkey-171c9.3 isoform X2
chloride channel, voltage-sensitive 5b, transcript variant X3
chloride channel, voltage-sensitive 5b, transcript variant X1
chloride channel, voltage-sensitive 5b, transcript variant X2
chloride channel, voltage-sensitive 5b, transcript variant X4
chloride channel, voltage-sensitive 5b, transcript variant X5
H(+)/Cl(-) exchange transporter 5 isoform X1
H(+)/Cl(-) exchange transporter 5 isoform X2
H(+)/Cl(-) exchange transporter 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
protein Shroom4-like, transcript variant X4
protein Shroom4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein Shroom4-like, transcript variant X3
protein Shroom4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase MID2 isoform X2
probable E3 ubiquitin-protein ligase MID2 isoform X1
Rho GTPase activating protein 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho GTPase activating protein 36, transcript variant X4
Rho GTPase activating protein 36, transcript variant X1
Rho GTPase activating protein 36, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 36 isoform X2
rho GTPase-activating protein 36 isoform X4
rho GTPase-activating protein 36 isoform X1
rho GTPase-activating protein 36 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
MORC family CW-type zinc finger protein 4-like
RNA binding motif protein 41, transcript variant X1
RNA binding motif protein 41, transcript variant X2
cytochrome c oxidase assembly protein COX11, mitochondrial, transcript variant X2
cytochrome c oxidase assembly protein COX11, mitochondrial, transcript variant X1
cytochrome c oxidase assembly protein COX11, mitochondrial, transcript variant X3
cytochrome c oxidase assembly protein COX11, mitochondrial, transcript variant X4
cytochrome c oxidase assembly protein COX11, mitochondrial, transcript variant X5
cytochrome c oxidase assembly protein COX11, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
FERM and PDZ domain-containing protein 3
phosphoribosyl pyrophosphate synthetase 1B, transcript variant X1
ribose-phosphate pyrophosphokinase 1 isoform X1
phosphoribosyl pyrophosphate synthetase 1B, transcript variant X2
ribose-phosphate pyrophosphokinase 1 isoform X2
solute carrier family 25 member 53-like, transcript variant X1
solute carrier family 25 member 53-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
membrane transport protein XK-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
membrane transport protein XK-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
membrane transport protein XK-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122557246, transcript variant X1
uncharacterized LOC122557246, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X2
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X1
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X3
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, transcript variant X4
transcription initiation factor TFIID subunit 1 isoform X1
transcription initiation factor TFIID subunit 1 isoform X2
transcription initiation factor TFIID subunit 1 isoform X3
uncharacterized LOC122557251, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122557251, transcript variant X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X2
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X1
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, transcript variant X3
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
discs, large homolog 3 (Drosophila), transcript variant X4
discs, large homolog 3 (Drosophila), transcript variant X3
discs, large homolog 3 (Drosophila), transcript variant X2
discs, large homolog 3 (Drosophila), transcript variant X1
discs, large homolog 3 (Drosophila), transcript variant X5
discs, large homolog 3 (Drosophila), transcript variant X6
RAB41, member RAS oncogene family, transcript variant X2
RAB41, member RAS oncogene family, transcript variant X1
P2Y purinoceptor 4-like, transcript variant X1
P2Y purinoceptor 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glycerophosphodiester phosphodiesterase domain containing 2
glycerophosphodiester phosphodiesterase domain-containing protein 5
kinesin family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PDZ domain containing 11, transcript variant X1
PDZ domain containing 11, transcript variant X2
PDZ domain containing 11, transcript variant X3
mediator complex subunit 12, transcript variant X1
mediator complex subunit 12, transcript variant X2
mediator of RNA polymerase II transcription subunit 12 isoform X1
mediator of RNA polymerase II transcription subunit 12 isoform X2
StAR-related lipid transfer (START) domain containing 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
high affinity cationic amino acid transporter 1-like
small nuclear ribonucleoprotein 35 (U11/U12), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
small nuclear ribonucleoprotein 35 (U11/U12), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
U11/U12 small nuclear ribonucleoprotein 35 kDa protein isoform X1
U11/U12 small nuclear ribonucleoprotein 35 kDa protein isoform X2
ubiquitin-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ubiquitin-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
cysteine and histidine-rich domain-containing protein 1-like
serine protease 23-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine protease 23-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
serine protease 23-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein-like, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein-like isoform X4
phosphatidylinositol-binding clathrin assembly protein-like isoform X1
phosphatidylinositol-binding clathrin assembly protein-like isoform X2
phosphatidylinositol-binding clathrin assembly protein-like isoform X3
von Hippel-Lindau binding protein 1, transcript variant X2
von Hippel-Lindau binding protein 1, transcript variant X1
von Hippel-Lindau binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
synaptotagmin-like protein 2, transcript variant X5
synaptotagmin-like protein 2, transcript variant X6
synaptotagmin-like protein 2, transcript variant X7
synaptotagmin-like protein 2, transcript variant X1
synaptotagmin-like protein 2, transcript variant X2
synaptotagmin-like protein 2, transcript variant X4
synaptotagmin-like protein 2, transcript variant X3
V-set and immunoglobulin domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
heat shock factor protein 1-like, transcript variant X2
heat shock factor protein 1-like isoform X2
heat shock factor protein 1-like, transcript variant X1
heat shock factor protein 1-like isoform X1
lysosomal-associated membrane protein 2, transcript variant X1
lysosome-associated membrane glycoprotein 2 isoform X1
lysosomal-associated membrane protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
lysosomal-associated membrane protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
lysosome-associated membrane glycoprotein 2 isoform X2
lysosomal-associated membrane protein 2, transcript variant X3
lysosome-associated membrane glycoprotein 2 isoform X3
C1GALT1-specific chaperone 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
C1GALT1-specific chaperone 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
paraspeckle component 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
paraspeckle component 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
paraspeckle component 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
paraspeckle component 1-like, transcript variant X5
paraspeckle component 1-like, transcript variant X1
paraspeckle component 1-like, transcript variant X3
paraspeckle component 1-like, transcript variant X2
non-POU domain-containing octamer-binding protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Rho GTPase activating protein 20b, transcript variant X2
Rho GTPase activating protein 20b, transcript variant X1
Rho GTPase activating protein 20b, transcript variant X3
rho GTPase-activating protein 20 isoform X1
rho GTPase-activating protein 20 isoform X2
rho GTPase-activating protein 20 isoform X3
Rho GTPase activating protein 20b, transcript variant X4
rho GTPase-activating protein 20 isoform X4
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger CCCH-type containing 12B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger CCCH-type containing 12B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
probable ribonuclease ZC3H12B isoform X1
probable ribonuclease ZC3H12B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
zinc finger C4H2 domain-containing protein
uncharacterized protein C8orf48-like, transcript variant X3
uncharacterized protein C8orf48-like, transcript variant X1
uncharacterized protein C8orf48 homolog isoform X3
uncharacterized protein C8orf48-like isoform X1
uncharacterized protein C8orf48-like, transcript variant X2
uncharacterized protein C8orf48 homolog isoform X2
RNA-binding protein with multiple splicing 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SOCS box-containing 12a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
APC membrane recruitment protein 1, transcript variant X2
APC membrane recruitment protein 1, transcript variant X1
APC membrane recruitment protein 1, transcript variant X3
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Cdc42 guanine nucleotide exchange factor (GEF) 9a, transcript variant X1
Cdc42 guanine nucleotide exchange factor (GEF) 9a, transcript variant X2
Cdc42 guanine nucleotide exchange factor (GEF) 9a, transcript variant X4
Cdc42 guanine nucleotide exchange factor (GEF) 9a, transcript variant X3
rho guanine nucleotide exchange factor 9 isoform X3
rho guanine nucleotide exchange factor 9 isoform X4
rho guanine nucleotide exchange factor 9 isoform X1
rho guanine nucleotide exchange factor 9 isoform X2
GRB2 associated binding protein 3, transcript variant X3
GRB2 associated binding protein 3, transcript variant X2
GRB2 associated binding protein 3, transcript variant X1
GRB2 associated binding protein 3, transcript variant X5
GRB2-associated-binding protein 3 isoform X3
GRB2-associated-binding protein 3 isoform X2
GRB2-associated-binding protein 3 isoform X1
GRB2-associated-binding protein 3 isoform X4
GRB2 associated binding protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1, transcript variant X2
probable global transcription activator SNF2L1 isoform X1
probable global transcription activator SNF2L1 isoform X2
teneurin transmembrane protein 1, transcript variant X2
teneurin transmembrane protein 1, transcript variant X1
teneurin transmembrane protein 1, transcript variant X4
teneurin transmembrane protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
teneurin transmembrane protein 1, transcript variant X6
teneurin transmembrane protein 1, transcript variant X5
E3 ubiquitin-protein ligase XIAP-like, transcript variant X5
E3 ubiquitin-protein ligase XIAP-like, transcript variant X8
E3 ubiquitin-protein ligase XIAP-like, transcript variant X3
E3 ubiquitin-protein ligase XIAP-like, transcript variant X4
E3 ubiquitin-protein ligase XIAP-like, transcript variant X1
E3 ubiquitin-protein ligase XIAP-like, transcript variant X2
E3 ubiquitin-protein ligase XIAP-like, transcript variant X11
E3 ubiquitin-protein ligase XIAP-like, transcript variant X6
E3 ubiquitin-protein ligase XIAP-like, transcript variant X10
E3 ubiquitin-protein ligase XIAP-like, transcript variant X9
E3 ubiquitin-protein ligase XIAP-like, transcript variant X7
E3 ubiquitin-protein ligase XIAP-like isoform X2
E3 ubiquitin-protein ligase XIAP-like isoform X1
stromal antigen 2b, transcript variant X4
stromal antigen 2b, transcript variant X5
stromal antigen 2b, transcript variant X1
stromal antigen 2b, transcript variant X3
stromal antigen 2b, transcript variant X2
stromal antigen 2b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
E3 ubiquitin-protein ligase MSL2-like, transcript variant X2
E3 ubiquitin-protein ligase MSL2-like isoform X2
E3 ubiquitin-protein ligase MSL2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
E3 ubiquitin-protein ligase MSL2-like isoform X1
E3 ubiquitin-protein ligase MSL2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC122557316, transcript variant X2
uncharacterized LOC122557316, transcript variant X3
uncharacterized LOC122557316, transcript variant X5
uncharacterized LOC122557316, transcript variant X1
uncharacterized LOC122557316, transcript variant X4
uncharacterized LOC122557509, transcript variant X1
uncharacterized LOC122557509, transcript variant X2
glutamate receptor, ionotropic, AMPA 3b, transcript variant X2
glutamate receptor, ionotropic, AMPA 3b, transcript variant X1
glutamate receptor, ionotropic, AMPA 3b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, AMPA 3b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, AMPA 3b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate receptor, ionotropic, AMPA 3b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamate receptor, ionotropic, AMPA 3b, transcript variant X7
uncharacterized LOC122557320, transcript variant X1
uncharacterized LOC122557320, transcript variant X2
kinase insert domain receptor like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kinase insert domain receptor like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vascular endothelial growth factor receptor kdr-like isoform X2
vascular endothelial growth factor receptor kdr-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
cysteine-rich hydrophobic domain-containing protein 1
pre-mRNA 3'-end-processing factor FIP1-like, transcript variant X1
pre-mRNA 3'-end-processing factor FIP1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
pre-mRNA 3'-end-processing factor FIP1-like isoform X1
pre-mRNA 3'-end-processing factor FIP1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ras-like protein family member 11A-like, transcript variant X2
ras-like protein family member 11A-like, transcript variant X4
ras-like protein family member 11A-like, transcript variant X5
ras-like protein family member 11A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ras-like protein family member 11A-like, transcript variant X3
ras-like protein family member 11A-like isoform X1
ras-like protein family member 11A-like isoform X2
ubiquitin carboxyl-terminal hydrolase 12-B, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 12-B, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 12-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 12 isoform X1
ubiquitin carboxyl-terminal hydrolase 12-B isoform X2
ubiquitin carboxyl-terminal hydrolase 12-B isoform X3
G-protein coupled receptor 12-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G-protein coupled receptor 12-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X2
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X6
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X1
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X4
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X5
wiskott-Aldrich syndrome protein family member 3-like, transcript variant X3
wiskott-Aldrich syndrome protein family member 3-like
immunoglobulin (CD79A) binding protein 1
uncharacterized LOC122557331, transcript variant X2
uncharacterized LOC122557331, transcript variant X3
uncharacterized LOC122557331, transcript variant X5
uncharacterized LOC122557331, transcript variant X1
uncharacterized LOC122557331, transcript variant X4
uncharacterized protein LOC122557331 isoform X1
uncharacterized protein LOC122557331 isoform X4
uncharacterized protein LOC122557331 isoform X3
uncharacterized protein LOC122557331 isoform X2
uncharacterized protein LOC122557331 isoform X5
gap junction beta-1 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gap junction beta-1 protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gap junction beta-1 protein-like isoform X2
gap junction beta-1 protein-like isoform X1
gap junction alpha-3 protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
gap junction alpha-3 protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gap junction alpha-3 protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger MYM-type protein 3-like, transcript variant X2
zinc finger MYM-type protein 3-like, transcript variant X3
zinc finger MYM-type protein 3-like, transcript variant X1
zinc finger MYM-type protein 3-like isoform X3
zinc finger MYM-type protein 3-like isoform X2
zinc finger MYM-type protein 3-like isoform X1
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytochrome c oxidase subunit 7B, mitochondrial
copper-transporting ATPase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
copper-transporting ATPase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
copper-transporting ATPase 1-like isoform X1
copper-transporting ATPase 1-like isoform X3
copper-transporting ATPase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
copper-transporting ATPase 1-like isoform X2
short transient receptor potential channel 5-like, transcript variant X1
short transient receptor potential channel 5-like, transcript variant X2
short transient receptor potential channel 5-like isoform X1
short transient receptor potential channel 5-like isoform X2
ALG13 UDP-N-acetylglucosaminyltransferase subunit
putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13
neuronal migration protein doublecortin-like, transcript variant X1
neuronal migration protein doublecortin-like, transcript variant X2
neuronal migration protein doublecortin-like isoform X1
neuronal migration protein doublecortin-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase PAK 3, transcript variant X2
serine/threonine-protein kinase PAK 3, transcript variant X5
serine/threonine-protein kinase PAK 3, transcript variant X6
serine/threonine-protein kinase PAK 3, transcript variant X1
serine/threonine-protein kinase PAK 3, transcript variant X4
serine/threonine-protein kinase PAK 3, transcript variant X9
serine/threonine-protein kinase PAK 3, transcript variant X8
serine/threonine-protein kinase PAK 3, transcript variant X7
serine/threonine-protein kinase PAK 3, transcript variant X3
serine/threonine-protein kinase PAK 3 isoform X4
serine/threonine-protein kinase PAK 3 isoform X3
serine/threonine-protein kinase PAK 3 isoform X2
serine/threonine-protein kinase PAK 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA synthetase long chain family member 4a, transcript variant X2
acyl-CoA synthetase long chain family member 4a, transcript variant X3
acyl-CoA synthetase long chain family member 4a, transcript variant X1
acyl-CoA synthetase long chain family member 4a, transcript variant X4
acyl-CoA synthetase long chain family member 4a, transcript variant X6
acyl-CoA synthetase long chain family member 4a, transcript variant X5
acyl-CoA synthetase long chain family member 4a, transcript variant X7
long-chain-fatty-acid--CoA ligase 4 isoform X1
long-chain-fatty-acid--CoA ligase 4 isoform X2
nuclear transport factor 2-like export factor 2, transcript variant X1
NTF2-related export protein 2 isoform X1
nuclear transport factor 2-like export factor 2, transcript variant X2
NTF2-related export protein 2 isoform X2
retinal guanylyl cyclase 2-like, transcript variant X1
retinal guanylyl cyclase 2-like, transcript variant X2
retinal guanylyl cyclase 2-like isoform X1
retinal guanylyl cyclase 2-like isoform X2
retinal guanylyl cyclase 2-like, transcript variant X3
retinal guanylyl cyclase 2-like isoform X3
transforming growth factor beta activator LRRC32-like, transcript variant X1
transforming growth factor beta activator LRRC32-like, transcript variant X2
transforming growth factor beta activator LRRC32-like isoform X1
transforming growth factor beta activator LRRC32-like isoform X2
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein Wnt-11b-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein Wnt-11b-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ATRX chromatin remodeler, transcript variant X3
ATRX chromatin remodeler, transcript variant X2
transcriptional regulator ATRX isoform X2
ATRX chromatin remodeler, transcript variant X1
transcriptional regulator ATRX isoform X1
transcriptional regulator ATRX isoform X3
fibroblast growth factor 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fibroblast growth factor 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122557359, transcript variant X1
uncharacterized LOC122557359, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 15b
uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)
uracil phosphoribosyltransferase homolog
ATP-binding cassette, sub-family B (MDR/TAP), member 7, transcript variant X4
ATP-binding cassette, sub-family B (MDR/TAP), member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATP-binding cassette, sub-family B (MDR/TAP), member 7, transcript variant X1
ATP-binding cassette, sub-family B (MDR/TAP), member 7, transcript variant X3
iron-sulfur clusters transporter ABCB7, mitochondrial isoform X2
iron-sulfur clusters transporter ABCB7, mitochondrial isoform X3
iron-sulfur clusters transporter ABCB7, mitochondrial isoform X1
iron-sulfur clusters transporter ABCB7, mitochondrial isoform X4
neurite extension and migration factor b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurite extension and migration factor b, transcript variant X3
neurite extension and migration factor b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neurite extension and migration factor b, transcript variant X4
ring finger protein, LIM domain interacting, transcript variant X1
E3 ubiquitin-protein ligase RNF12-B isoform X1
ring finger protein, LIM domain interacting, transcript variant X2
E3 ubiquitin-protein ligase RNF12-B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
cytokine receptor common subunit gamma-like
cytokine receptor common subunit gamma-like, transcript variant X1
cytokine receptor common subunit gamma-like, transcript variant X3
cytokine receptor common subunit gamma-like, transcript variant X2
cytokine receptor common subunit gamma-like isoform X2
cytokine receptor common subunit gamma-like isoform X3
cytokine receptor common subunit gamma-like isoform X1
proteasome 26S subunit, non-ATPase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
proteasome 26S subunit, non-ATPase 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 10 isoform X1
26S proteasome non-ATPase regulatory subunit 10 isoform X2
autophagy related 4A, cysteine peptidase
tumor necrosis factor ligand superfamily member 13B-like, transcript variant X1
tumor necrosis factor ligand superfamily member 13B-like, transcript variant X3
tumor necrosis factor ligand superfamily member 13B-like, transcript variant X2
tumor necrosis factor ligand superfamily member 13B-like isoform X3
tumor necrosis factor ligand superfamily member 13B-like isoform X1
tumor necrosis factor ligand superfamily member 13B-like isoform X2
uncharacterized LOC122557380, transcript variant X2
uncharacterized LOC122557380, transcript variant X1
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X2
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X1
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X6
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X3
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X8
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X7
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X5
collagen, type IV, alpha 5 (Alport syndrome), transcript variant X4
collagen, type IV, alpha 6, transcript variant X4
collagen, type IV, alpha 6, transcript variant X1
collagen, type IV, alpha 6, transcript variant X3
collagen, type IV, alpha 6, transcript variant X5
collagen, type IV, alpha 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
NALCN channel auxiliary factor 2, transcript variant X1
NALCN channel auxiliary factor 2, transcript variant X2
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
beta-arrestin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-arrestin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-arrestin-1-like, transcript variant X2
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
uncharacterized LOC122557394, transcript variant X3
uncharacterized LOC122557394, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122557394, transcript variant X2
uncharacterized protein LOC122557394 isoform X1
uncharacterized protein LOC122557394 isoform X3
uncharacterized protein LOC122557394 isoform X2
uncharacterized LOC122557393, transcript variant X1
uncharacterized LOC122557393, transcript variant X2
uncharacterized protein LOC122557393 isoform X1
uncharacterized protein LOC122557393 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transcription factor Dp-1-like, transcript variant X2
transcription factor Dp-1-like, transcript variant X1
transcription factor Dp-1-like isoform X1
transcription factor Dp-1-like, transcript variant X4
transcription factor Dp-1-like, transcript variant X5
transcription factor Dp-1-like, transcript variant X3
transcription factor Dp-1-like isoform X2
protein ATP1B4-like, transcript variant X4
protein ATP1B4-like, transcript variant X3
protein ATP1B4-like, transcript variant X5
protein ATP1B4-like, transcript variant X1
protein ATP1B4-like, transcript variant X2
transmembrane protein 255A, transcript variant X2
transmembrane protein 255A, transcript variant X1
transmembrane protein 255A, transcript variant X3
zinc finger and BTB domain containing 33, transcript variant X1
zinc finger and BTB domain containing 33, transcript variant X3
zinc finger and BTB domain containing 33, transcript variant X2
NFKB activating protein, transcript variant X1
NF-kappa-B-activating protein isoform X1
NFKB activating protein, transcript variant X2
NF-kappa-B-activating protein isoform X2
A-kinase anchoring protein 14, transcript variant X1
A-kinase anchoring protein 14, transcript variant X2
NADH:ubiquinone oxidoreductase subunit A1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1
UPF3B regulator of nonsense mediated mRNA decay
sosondowah ankyrin repeat domain family d
ankyrin repeat domain-containing protein SOWAHD
ubiquitin-conjugating enzyme E2A (RAD6 homolog), transcript variant X2
ubiquitin-conjugating enzyme E2A (RAD6 homolog), transcript variant X1
ubiquitin-conjugating enzyme E2 A isoform X1
ubiquitin-conjugating enzyme E2 A isoform X2
uncharacterized protein si:rp71-46j2.7 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
ankyrin repeat domain-containing protein 46, transcript variant X1
ankyrin repeat domain-containing protein 46, transcript variant X2
ankyrin repeat domain-containing protein 46 isoform X1
ankyrin repeat domain-containing protein 46 isoform X2
transmembrane protein 185, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane protein 185, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transmembrane protein 185-like isoform X1
transmembrane protein 185-like isoform X2
heat shock transcription factor, Y-linked-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC550336 homolog, transcript variant X2
uncharacterized protein LOC550336 homolog, transcript variant X4
uncharacterized protein LOC550336 homolog, transcript variant X3
uncharacterized protein LOC550336 homolog, transcript variant X1
myotubularin related protein 1b, transcript variant X1
myotubularin related protein 1b, transcript variant X3
myotubularin related protein 1b, transcript variant X2
myotubularin related protein 1b, transcript variant X4
myotubularin-related protein 1b isoform X1
myotubularin-related protein 1b isoform X3
myotubularin-related protein 1b isoform X2
myotubularin-related protein 1b isoform X4
myotubularin related protein 1b, transcript variant X5
myotubularin-related protein 1b isoform X5
CD99 molecule-like 2, transcript variant X2
CD99 molecule-like 2, transcript variant X6
CD99 molecule-like 2, transcript variant X1
CD99 molecule-like 2, transcript variant X3
CD99 molecule-like 2, transcript variant X5
CD99 molecule-like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
vacuolar ATPase assembly integral membrane protein vma21
neuronal PAS domain protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal PAS domain protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal PAS domain protein 2, transcript variant X2
neuronal PAS domain protein 2, transcript variant X3
neuronal PAS domain protein 2, transcript variant X1
neuronal PAS domain protein 2, transcript variant X4
neuronal PAS domain-containing protein 2 isoform X3
neuronal PAS domain-containing protein 2 isoform X2
neuronal PAS domain-containing protein 2 isoform X1
neuronal PAS domain protein 2, transcript variant X7
neuronal PAS domain-containing protein 2 isoform X4
TBC1 domain family member 8B, transcript variant X2
TBC1 domain family member 8B, transcript variant X1
TBC1 domain family member 8B, transcript variant X3
TBC1 domain family member 8B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF128, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF128, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF128 isoform X2
E3 ubiquitin-protein ligase RNF128 isoform X1
RPA1 related single stranded DNA binding protein, transcript variant X3
RPA1 related single stranded DNA binding protein, transcript variant X4
RPA1 related single stranded DNA binding protein, transcript variant X1
RPA1 related single stranded DNA binding protein, transcript variant X2
mitogen-activated protein kinase kinase kinase kinase 4, transcript variant X4
mitogen-activated protein kinase kinase kinase kinase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase kinase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase kinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase kinase 4 isoform X3
mitogen-activated protein kinase kinase kinase kinase 4 isoform X2
mitogen-activated protein kinase kinase kinase kinase 4 isoform X1
mitogen-activated protein kinase kinase kinase kinase 4 isoform X4
interleukin 1 receptor accessory protein-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interleukin 1 receptor accessory protein-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
X-linked interleukin-1 receptor accessory protein-like 2
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
aristaless-related homeobox protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 199, X-linked, transcript variant X1
family with sequence similarity 199, X-linked, transcript variant X2
COMM domain containing 5, transcript variant X3
COMM domain containing 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
COMM domain containing 5, transcript variant X1
COMM domain containing 5, transcript variant X2
COMM domain-containing protein 5 isoform X2
COMM domain-containing protein 5 isoform X1
COMM domain-containing protein 5 isoform X3
LON peptidase N-terminal domain and RING finger protein 3-like
uncharacterized protein LOC321250 homolog, transcript variant X3
uncharacterized protein LOC321250 homolog, transcript variant X2
uncharacterized protein LOC321250 homolog, transcript variant X1
iduronate 2-sulfatase, transcript variant X1
iduronate 2-sulfatase, transcript variant X2
iduronate 2-sulfatase, transcript variant X3
AF4/FMR2 family, member 2, transcript variant X2
AF4/FMR2 family, member 2, transcript variant X1
AF4/FMR2 family, member 2, transcript variant X3
FMRP translational regulator 1, transcript variant X6
FMRP translational regulator 1, transcript variant X1
FMRP translational regulator 1, transcript variant X2
FMRP translational regulator 1, transcript variant X3
FMRP translational regulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
FMRP translational regulator 1, transcript variant X4
synaptic functional regulator FMR1 isoform X1
synaptic functional regulator FMR1 isoform X2
synaptic functional regulator FMR1 isoform X3
synaptic functional regulator FMR1 isoform X4
synaptic functional regulator FMR1 isoform X5
synaptic functional regulator FMR1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
SLIT and NTRK-like family, member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SLIT and NTRK-like family, member 4, transcript variant X7
SLIT and NTRK-like family, member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SLIT and NTRK-like family, member 4, transcript variant X3
SLIT and NTRK-like family, member 4, transcript variant X5
SLIT and NTRK-like family, member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SLIT and NTRK-like family, member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50% coverage of the annotated genomic feature by RNAseq alignments
phospholipid-transporting ATPase IH-like, transcript variant X6
phospholipid-transporting ATPase IG-like isoform X4
phospholipid-transporting ATPase IH-like, transcript variant X4
phospholipid-transporting ATPase IH-like, transcript variant X5
phospholipid-transporting ATPase IH-like, transcript variant X3
phospholipid-transporting ATPase IH-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phospholipid-transporting ATPase IH-like, transcript variant X1
phospholipid-transporting ATPase IH-like, transcript variant X2
phospholipid-transporting ATPase IG-like isoform X3
phospholipid-transporting ATPase IG-like isoform X1
phospholipid-transporting ATPase IH-like isoform X2
phospholipid-transporting ATPase IH-like isoform X6
phospholipid-transporting ATPase IH-like, transcript variant X7
phospholipid-transporting ATPase IG-like isoform X5
MCF.2 cell line derived transforming sequence a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
coagulation factor IX-like, transcript variant X3
coagulation factor IX-like, transcript variant X1
coagulation factor IX-like, transcript variant X2
fat storage-inducing transmembrane protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
fibroblast growth factor 13-like, transcript variant X4
fibroblast growth factor 13-like isoform X4
fibroblast growth factor 13-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fibroblast growth factor 13-like isoform X3
fibroblast growth factor 13-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor 13-like isoform X2
fibroblast growth factor 13-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fibroblast growth factor 13-like isoform X1
transmembrane 9 superfamily member 2-like
RNA binding motif protein X-linked, transcript variant X4
RNA binding motif protein X-linked, transcript variant X2
RNA binding motif protein X-linked, transcript variant X1
RNA binding motif protein X-linked, transcript variant X3
RNA-binding motif protein, X chromosome isoform X1
RNA-binding motif protein, X chromosome isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00270
uncharacterized LOC122557449, transcript variant X1
uncharacterized LOC122557449, transcript variant X2
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6, transcript variant X1
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6, transcript variant X2
rho guanine nucleotide exchange factor 6 isoform X1
rho guanine nucleotide exchange factor 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
cytokine-dependent hematopoietic cell linker-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
adhesion G-protein coupled receptor G4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments